HK Stock Market Move | TH MEDICAL-B (02697) rose over 6% in the afternoon after the company signed a sales contract worth nearly 100 million yuan for a puncture surgery navigation positioning system.

TH MEDICAL-B (02697) rose over 6% in the afternoon; as of the time of writing, it was up 5.79%, trading at HKD 666.5, with a transaction volume of HKD 14.5251 million. On the news front, on August 31, Zhenjiankang Medical announced that the company had signed a sales contract with an independent third party to sell puncture surgery navigation systems to the buyer. The total contract amount is close to RMB 100 million, and the relevant products will be delivered in batches in the near future. Industry analysts believe that this nearly RMB 100 million contract not only provides new support for Zhenjiankang Medical to continue expanding its medical institution client base, enhancing market coverage, and accelerating business scale development, but also sets a new benchmark for the development of the Siasun Robot & Automation segment in the field of percutaneous puncture surgery. It is worth noting that Zhenjiankang Medical recently released its first mid-term results post-IPO, reporting revenue of RMB 5.671 million in the first half of the year, a year-on-year increase of nearly 32 times, with sales revenue from surgical Siasun Robot & Automation accounting for 91.0%. Revenue from consumables grew 135.8% year-on-year. The "equipment + consumables" business model has already been proven successful, and the momentum of consumables driven by equipment is accelerating. The bulk delivery of this order will inject greater growth momentum into this model.